Exon sequence is required for regulated RNA splicing of the human fibroblast growth factor receptor-1 alpha-exon.

The Journal of Biological Chemistry
W JinG J Cote

Abstract

Alternative RNA processing of the human fibroblast growth factor receptor-1 transcript results in receptor forms that vary in their affinity for fibroblast growth factor. An alternative RNA processing event involving recognition of the alpha-exon is deregulated during neoplastic transformation of glial cells. We have previously established a splicing reporter/transfection cell culture model system to identify sequences involved in recognition of this exon. In this study, the system was used to identify two sequence elements that differentially function to regulate splicing of this exon. Exclusion of the alpha-exon in glioblastoma cells specifically required the downstream intron sequence comprising the 5'-splice site. Replacement or mutation of this sequence increasing complementarity to U1 RNA resulted in enhanced exon recognition in SNB-19 glioblastoma cells. Sequences within the exon were found to be required for alpha-exon inclusion. Deletion and gain-of-function experiments identified a 69-nucleotide exon sequence that was specifically required for alpha-exon inclusion. These studies indicate that multiple sequences are required for the regulated recognition of the alpha-exon.

References

May 1, 1995·Cell Biology International·J S RubinP W Finch
Sep 1, 1994·Molecular Reproduction and Development·W L McKeehan, M Kan
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·F YamaguchiR S Morrison
Mar 1, 1993·Genes & Development·A WatakabeY Shimura
Jul 1, 1996·Genes & Development·J L Manley, R Tacke
Jun 1, 1996·Current Opinion in Cell Biology·M D AdamsD C Rio
Aug 1, 1996·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P J GreenP Doherty
Jun 1, 1996·Current Biology : CB·I Mason
Nov 1, 1996·Trends in Genetics : TIG·B Chabot
Apr 1, 1997·Molecular and Cellular Biology·L R CoulterT A Cooper
May 1, 1997·Trends in Genetics : TIG·M K Webster, D J Donoghue
Jun 1, 1997·Current Opinion in Cell Biology·K J HertelT Maniatis
Jul 14, 1998·Molecular Cell·K J Hertel, T Maniatis

❮ Previous
Next ❯

Citations

Apr 1, 2003·Molecular and Cellular Biology·Sònia GuilMontse Bach-Elias
Apr 11, 2001·Endocrine Reviews·H Lou, R F Gagel
Apr 16, 2014·Journal of Cellular Physiology·Siew-Ging Gong
Feb 20, 2007·Molecular Cancer Therapeutics·Kathleen M DiehlKathleen M Woods Ignatoski

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.